Closeup of a Petri Dish

OUR BOARD

We are a team of senior executives with significant experience in establishing and growing businesses in the private and public sectors.

 

STEPHEN WEST

Executive Chairman

Stephen is a Fellow Chartered Accountant with over 26 years of financial and corporate experience gained in public practice, the resource sector and investment banking. Stephen has a proven track record in working with growth companies with extensive experience in IPOs, secondary listings, corporate finance, fundraising, investor relations and financial and management reporting. Stephen is currently CFO and executive director of AIM listed Advance Energy plc and non-executive Chairman of Zeta Petroleum plc.

DR MICHAEL STEIN

Non-Executive Director

Michael is a business leader and strategic adviser with C-suite experience in healthcare. Michael was the founding CEO of Valo Therapeutics and also of OxStem Ltd, an award-winning biotechnology spin-out from the University of Oxford, which broke the UK record for a seed round fund-raise of over £16m in May 2016.

In addition, Michael has served as founding CEO for Doctor Care Anywhere, acquired by Synergix in 2015. In 2001, he co-founded the Map of Medicine Ltd (the Map) with University College London. As founding CEO (and later CMO), the Map was nationally licensed across NHS England (2005-15) and acquired by Hearst Business Media (HBM) in 2008, after which Michael transitioned to executive vice-president of healthcare innovation.


Michael graduated as a medical doctor (Honours) and biochemist (First Class Honours) from the University of Cape Town (1988) and from the University of Oxford (Rhodes Scholar) with a doctorate in Physiological Sciences (Immunology). He subsequently was appointed as a Junior Research Fellow in Medicine at Trinity College, Oxford (1992-95) having been a part-time lecturer in Immunology and Pathology at Balliol College, Oxford (1988-91). As a medical scientist, Michael first described the alternative pathway of macrophage activation, now known as the M2 phenotype (J Exp Med. 1992 Jul 1;176(1):287-92). In addition, Michael co-authored the best-selling UK medical handbook entitled The Hands on Guide to House Officers, Blackwell Science (1996), until it's 5th edition as The Hands on Guide to the Foundation Programme in 2014 (Blackwell-Wiley).

GLENN WHIDDON

Non-Executive Director

Glenn holds a degree in Economics from Macquarie University and has extensive corporate and management experience, with a background in equity capital markets, banking and corporate advisory.  Glenn is currently a director of a number of Australian and international public listed companies.

MARK ROLLINS

Non-Executive Director

Mark holds doctorate in Engineering Science from Oxford University, as well as a Masters in Mathematics from Cambridge University. Mark has a proven commercial track record with extensive experience in business development, government negotiation and private equity. Mark is currently non-executive chairman of AIM listed Advance Energy plc.  Mr Rollins previously held senior positions at several large listed companies including Chairman and CEO of Ukrnafta in Ukraine with over 20,000 employees, and Senior VP at BG Group plc and Shell International.